Rheumatoid arthritis synovial macrophages express the Fas-associated death domain - Like interleukin-1β - Converting enzyme - Inhibitory protein and are refractory to Fas-mediated apoptosis

Arthritis and Rheumatism

Volumn 44, Issue 1, 2001, Pages 21-30

  Perlman, Harris ^a   Pagliari, Lisa J ^a   Liu, Hongtao ^a   Koch, Alisa E ^a   Haines III, G Kenneth ^a   Pope, Richard M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD14 ANTIGEN; CD68 ANTIGEN; FAS ANTIBODY; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MONONUCLEAR CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CYSTEINE PROTEINASE INHIBITORS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE; MACROPHAGES; MONOCYTES; SERPINS; SYNOVIAL MEMBRANE; VIRAL PROTEINS;

EID: 0035147059     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8     Document Type: Article

References (57)

1. Invasive fibroblast-like synoviocytes in rheumatoid arthritis
2. Role of cytokines in rheumatoid arthritis
3. Synovial tissue macrophages and joint erosion in rheumatoid arthritis
4. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
5. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
6. The Fas death factor
7. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
8. Apoptosis signaling by death receptors
9. Caspases: Enemies within
10. Inhibition of death receptor signals by cellular FLIP
11. FLICE inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
12. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
13. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
14. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP
15. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-κB
16. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
17. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation
18. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry
19. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer
20. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
21. Bax-mediated cell death by the Gax homeoprotein requires mitogen-activation but is independent of cell cycle activity
22. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis
23. Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis
24. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
25. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts
26. Phagocytosis triggers macrophage release of Fas ligand induces apoptosis in bystander leukocytes
27. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium
28. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway
29. Regulation of human monocyte apoptosis by the CD14 molecule
30. Monocyte CD14: A multifunctional receptor engaged in apoptosis from both sides
31. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
32. The role of macrophages in chronic arthritis
33. Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice
34. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis
35. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1
36. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis
37. Protein kinase C (PKC) inhibits Fas receptor-induced apoptosis through modulation of the loss of K+ cell shirnkage: A role for PKC upstream of Caspases
38. Activation of protein kinase C attenuates early signals in Fas-mediated apoptosis
39. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases
40. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmaleimide
41. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
42. Inhibition of Fas death signals by FLIPs
43. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
44. Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model
45. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
46. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
47. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
48. Tumor expression of Fas ligand and the consequences
49. TNFα regulation of Fas ligand expression on vascular endothelium modulates leukocyte extravasation
50. Programmed cell death of embryonic motor neurons triggered through the fas death receptor
51. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
52. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
53. Oncoprotein expression in human synovial tissue: An immunohistochemical study of different types of arthritis
54. Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue
55. Nuclear factor-κB in rheumatoid synovium
56. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy
57. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint